JD Health International (FRA:8ZN) EBIT per Share : €0.11 (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is JD Health International EBIT per Share?

JD Health International's EBIT per Share for the six months ended in Dec. 2023 was €0.04. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.11.

During the past 3 years, the average EBIT per Share Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for JD Health International's EBIT per Share or its related term are showing as below:

FRA:8ZN' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 8.6 Med: 16.75 Max: 24.9
Current: 8.6

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of JD Health International was 24.90% per year. The lowest was 8.60% per year. And the median was 16.75% per year.

FRA:8ZN's 3-Year EBIT Growth Rate is ranked worse than
50.1% of 509 companies
in the Healthcare Providers & Services industry
Industry Median: 8.6 vs FRA:8ZN: 8.60

JD Health International's EBIT for the six months ended in Dec. 2023 was €111 Mil.

JD Health International EBIT per Share Historical Data

The historical data trend for JD Health International's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JD Health International EBIT per Share Chart

JD Health International Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.03

-0.97

-0.04

0.03

0.11

JD Health International Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial							-0.03	0.02	0.01	0.08	0.04

JD Health International EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

JD Health International's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	347.119	/	3163.985
=	0.11

JD Health International's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	111.375	/	3165.458
=	0.04

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.11

JD Health International (FRA:8ZN) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

JD Health International EBIT per Share Related Terms

Thank you for viewing the detailed overview of JD Health International's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

JD Health International (FRA:8ZN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (FRA:8ZN) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

JDHIY:USA JDHIF:USA 06618:Hong Kong 8ZN:Germany

Address

No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111

Website

https://ir.jdhealth.com

JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.

JD Health International (FRA:8ZN) Headlines

No Headlines